Therapeutic management of a patient with a unique factor IX sensitivity to warfarin.
Scranton Temple Residency Program, Scranton, Pa, USA.
Salvatore
S
Scialla
Ronald
R
Rubin
Kristin M
KM
Liptock
D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects*; D001026:Coronary Artery Bypass; D005164:Factor IX / Q000032:analysis / Q000235:genetics; D005500:Follow-Up Studies; D006406:Hematoma / Q000097:blood / Q000139:chemically induced*; D006470:Hemorrhage / Q000097:blood / Q000139:chemically induced* / Q000188:drug therapy*; D006801:Humans; D008297:Male; D014859:Warfarin / Q000008:administration & dosage / Q000009:adverse effects*
D000925:Anticoagulants; D014859:Warfarin; D005164:Factor IX